These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 23588320)

  • 1. Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver.
    Chu X; Korzekwa K; Elsby R; Fenner K; Galetin A; Lai Y; Matsson P; Moss A; Nagar S; Rosania GR; Bai JP; Polli JW; Sugiyama Y; Brouwer KL;
    Clin Pharmacol Ther; 2013 Jul; 94(1):126-41. PubMed ID: 23588320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transporters in hepatic drug disposition: an update.
    Li P; Wang GJ; Robertson TA; Roberts MS
    Curr Drug Metab; 2009 Jun; 10(5):482-98. PubMed ID: 19689245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites.
    Patel M; Taskar KS; Zamek-Gliszczynski MJ
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S23-39. PubMed ID: 27385177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A perspective on efflux transport proteins in the liver.
    Köck K; Brouwer KL
    Clin Pharmacol Ther; 2012 Nov; 92(5):599-612. PubMed ID: 22948894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sandwich-Cultured Hepatocytes for Mechanistic Understanding of Hepatic Disposition of Parent Drugs and Metabolites by Transporter-Enzyme Interplay.
    Matsunaga N; Fukuchi Y; Imawaka H; Tamai I
    Drug Metab Dispos; 2018 May; 46(5):680-691. PubMed ID: 29352067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the Interplay Between Uptake and Efflux Transporters Within In Vitro Systems in Defining Hepatocellular Drug Concentrations.
    Cantrill C; Houston JB
    J Pharm Sci; 2017 Sep; 106(9):2815-2825. PubMed ID: 28478131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Hepatic Efflux Transporter-Mediated Drug Interactions: When Is it Optimal to Measure Intracellular Unbound Fraction of Inhibitors?
    Guo C; Yang K; Liao M; Xia CQ; Brouwer KR; Brouwer KLR
    J Pharm Sci; 2017 Sep; 106(9):2401-2406. PubMed ID: 28465154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug transport proteins in the liver.
    Faber KN; Müller M; Jansen PL
    Adv Drug Deliv Rev; 2003 Jan; 55(1):107-24. PubMed ID: 12535576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters.
    Ramboer E; Vanhaecke T; Rogiers V; Vinken M
    Drug Metab Rev; 2013 May; 45(2):196-217. PubMed ID: 23368091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humans.
    Zamek-Gliszczynski MJ; Lee CA; Poirier A; Bentz J; Chu X; Ellens H; Ishikawa T; Jamei M; Kalvass JC; Nagar S; Pang KS; Korzekwa K; Swaan PW; Taub ME; Zhao P; Galetin A;
    Clin Pharmacol Ther; 2013 Jul; 94(1):64-79. PubMed ID: 23588311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Interactions of Epacadostat and its Major Metabolites with Human Efflux and Uptake Transporters: Implications for Pharmacokinetics and Drug Interactions.
    Zhang Q; Zhang Y; Boer J; Shi JG; Hu P; Diamond S; Yeleswaram S
    Drug Metab Dispos; 2017 Jun; 45(6):612-623. PubMed ID: 28283500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of pharmacokinetics and drug-drug interactions when hepatic transporters are involved.
    Li R; Barton HA; Varma MV
    Clin Pharmacokinet; 2014 Aug; 53(8):659-78. PubMed ID: 25056496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane transport as a determinant of the hepatic elimination of drugs and metabolites.
    Evans AM
    Clin Exp Pharmacol Physiol; 1996; 23(10-11):970-4. PubMed ID: 8911743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-protein interactions of drug uptake transporters that are important for liver and kidney.
    Zhang Y; Hagenbuch B
    Biochem Pharmacol; 2019 Oct; 168():384-391. PubMed ID: 31381872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport vs. Metabolism: What Determines the Pharmacokinetics and Pharmacodynamics of Drugs? Insights From the Extended Clearance Model.
    Patilea-Vrana G; Unadkat JD
    Clin Pharmacol Ther; 2016 Nov; 100(5):413-418. PubMed ID: 27448198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic modeling of the hepatobiliary transport mediated by cooperation of uptake and efflux transporters.
    Kusuhara H; Sugiyama Y
    Drug Metab Rev; 2010 Aug; 42(3):539-50. PubMed ID: 20175646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Sinusoidal Drug Uptake Transporter Activities in Primary Human Hepatocytes.
    Le Vée M; Jouan E; Denizot C; Parmentier Y; Fardel O
    Methods Mol Biol; 2015; 1250():287-302. PubMed ID: 26272151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industry.
    Soars MG; Webborn PJ; Riley RJ
    Mol Pharm; 2009; 6(6):1662-77. PubMed ID: 19402709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug transporters in pharmacokinetics.
    Petzinger E; Geyer J
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Mar; 372(6):465-75. PubMed ID: 16532306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.
    Feng B; Varma MV; Costales C; Zhang H; Tremaine L
    Expert Opin Drug Discov; 2014 Aug; 9(8):873-90. PubMed ID: 24857286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.